sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Aug-2014 21:36
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 476-500 out of 891.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>

Public Release: 8-Aug-2013
Journal of Clinical Investigation
Engineered rice protects against rotavirus infection
In the current issue of the Journal of Clinical Investigation, Yoshikazu Yuki and colleagues at the University of Tokyo report the development of a strain of rice that produces a rotavirus-specific antibody.
Programs of Special Coordination Funds for Promoting Science and Technology

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 7-Aug-2013
Nature
The temperature tastes just right
Animals have evolved very sensitive temperature sensors to detect the relatively narrow margin in which they can survive. Until recently, scientists knew little about how these sensors operated. Now, a team of Brandeis University scientists has discovered a previously unknown molecular temperature sensor in fruit flies responsible for sensing tastes and smells. These types of sensors are present in disease-spreading insects like mosquitoes and may help scientists better understand how insects target humans and spread disease.

Contact: Deb Filcman
filcman@brandeis.edu
781-736-4212
Brandeis University

Public Release: 2-Aug-2013
Journal of Biological Chemistry
New findings could influence the development of therapies to treat dengue disease
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.

Contact: Philippa Walker
philippa.walker@bristol.ac.uk
44-117-928-7777
University of Bristol

Public Release: 1-Aug-2013
Biomicrofluidics
Catching cancer early by chasing it
Reaching a clinic in time to receive an early diagnosis for cancer -- when the disease is most treatable -- is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

Contact: Jason Socrates Bardi
jbardi@aip.org
240-535-4954
American Institute of Physics

Public Release: 1-Aug-2013
Boston Medical Center and BU School of Medicine partner with Jawaharlal Institute to study TB
Boston Medical Center and Boston University School of Medicine are partnering with the Jawaharlal Institute of Postgraduate Medical Education and Research to study tuberculosis. This research is supported by a five-year, $2.5 million grant from the Indo-US Vaccine Action Program.
the Indo-U.S. Vaccine Action Program

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center

Public Release: 1-Aug-2013
International Journal of Mobile Learning and Organisation
An app to lead the blind
A smartphone app that keeps track of your location and distance walked from home or hotel and warns you when you are likely to be caught out after dark has been developed by researchers in Pakistan to help sufferers of the debilitating disease night blindness. The app can also help travelers with the disease pinpoint hotels should they find themselves too far from base to get home safely.

Contact: Albert Ang
press@inderscience.com
Inderscience Publishers

Public Release: 30-Jul-2013
Child Development
Disabled children treated more harshly in developing world
Children with disabilities receive harsher punishment across the developing world, according to a new study based on interviews with nearly 46,000 caregivers in 17 low- to middle-income countries.
National Institutes of Health

Contact: Alison Jones
alison.jones@duke.edu
919-681-8504
Duke University

Public Release: 30-Jul-2013
Child Development
Children with disabilities in developing countries at risk for harsher punishment
Children with disabilities who live in developing countries are more likely to experience harsh punishment than children without disabilities in those countries. It is estimated that 80 percent of those with a disability are living in low- or middle-income countries. Researchers looked at data from 46,000 parents and other caregivers of 2- to 9-year-olds in 17 low- and middle-income countries. They found that children with disabilities are especially vulnerable to abuse, exploitation, and violence.
NIH/Eunice Kennedy Shriver National Institute of Child Health

Contact: Sarah Mandell
smandell@srcd.org
202-289-7903
Society for Research in Child Development

Public Release: 29-Jul-2013
Proceedings of the National Academy of Sciences
New modular vaccine design combines best of existing vaccine technologies
Boston Children's researchers develop new method of vaccine design -- Multiple Antigen Presentation System. It could speed new vaccine development for range of globally serious pathogens, infectious agents. Method permits rapid construction of new vaccines that bring together benefits of whole-cell and acellular or defined subunit vaccination and activate mulitple arms of the immune system simultaneously against one or more pathogens, generating robust immune protection with lower risk of adverse effects.
Boston Children's Hospital

Contact: Meghan Weber
meghan.weber@childrens.harvard.edu
617-919-3110
Boston Children's Hospital

Public Release: 28-Jul-2013
Nature Chemistry
Breakthrough in detecting DNA mutations could help treat tuberculosis, cancer
Researchers at the University of Washington and Rice University have developed a new method that can look at a specific segment of DNA and pinpoint a single mutation, which could help diagnose and treat diseases such as cancer and tuberculosis.

Contact: Michelle Ma
mcma@uw.edu
206-543-2580
University of Washington

Public Release: 25-Jul-2013
Clinical Infectious Diseases
Miriam researcher helps develop global hepatitis C recommendations for injection-drug users
Dr. Lynn Taylor from The Miriam Hospital in Providence, RI was the only US researcher invited to join an expert panel to develop the first international recommendations for treating hepatitis C in people who inject drugs. She also wrote a separate paper calling for improved HCV care for individuals who are infected with both hepatitis C and HIV and also inject drugs.

Contact: Jessica Collins Grimes
jgrimes2@lifespan.org
Lifespan

Public Release: 24-Jul-2013
Clinical Infectious Diseases
Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C
The burden of liver disease could be dramatically reduced by scaling up the combination of interventions for hepatitis C infection among people who inject drugs according to University of Bristol researchers. The findings, published today [24 July], form part of new global recommendations on treating the virus.

Contact: Caroline Clancy
caroline.clancy@bristol.ac.uk
44-011-792-88086
University of Bristol

Public Release: 23-Jul-2013
Applied and Environmental Microbiology
Natural pest control protein effective against hookworm: A billion could benefit
A benign crystal protein, produced naturally by bacteria and used as an organic pesticide, could be a safe, inexpensive treatment for parasitic worms in humans and provide effective relief to over a billion people around the world. Researchers from the University of California, San Diego, La Jolla, CA, report on this potentially promising solution in a study published ahead of print in the journal Applied and Environmental Microbiology.

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology

Public Release: 23-Jul-2013
Cell Host & Microbe
Mount Sinai researchers identify vulnerabilities of the deadly Ebola virus
Disabling a protein in Ebola virus cells can stop the virus from replicating and infecting the host, according to researchers from the Icahn School of Medicine at Mount Sinai.

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 23-Jul-2013
University of Tennessee professors explore end-of-life needs for HIV/AIDS patients
Approximately 10,000 Americans die with an HIV/AIDS diagnosis each year, and many of these patients lack access to the care they need at the end of their lives. This is especially true for those who live in the Appalachian region. A group of nursing professors at the University of Tennessee, Knoxville, is embarking on a study to try to change this.
National Institutes of Health

Contact: Whitney Heins
wheins@utk.edu
865-974-5460
University of Tennessee at Knoxville

Public Release: 22-Jul-2013
Proceedings of the National Academy of Sciences
Off-grid sterilization with Rice U.'s 'solar steam'
Rice University nanotechnology researchers have unveiled a solar-powered sterilization system that could be a boon for more than 2.5 billion people who lack adequate sanitation. The "solar steam" sterilization system uses nanomaterials to convert as much as 80 percent of the energy in sunlight into germ-killing heat. The technology is described online in the Proceedings of the National Academy of Sciences Early Edition.
Bill & Melinda Gates Foundation, Welch Foundation

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University

Public Release: 22-Jul-2013
mBio
Study lays groundwork for norovirus anti-viral treatments
There's no vaccine to prevent norovirus, or drugs to treat the pesky virus that sickens millions each year and is known to complicate cruise ship vacations. But a first ever small animal model created at the University of Michigan Medical School provides a new tool to develop anti-viral treatments.
National Institutes of Health

Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 19-Jul-2013
PLOS Currents
Researchers describe potential for MERS coronavirus to spread internationally
The life-threatening MERS coronavirus that has emerged in the Middle East could spread faster and wider during two international mass gatherings involving millions of people in the next few months, according to researchers who describe the most likely pathways of international spread based upon worldwide patterns of air travel.
Canadian Institutes of Health Research, US Centers for Disease Control and Prevention

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 19-Jul-2013
Science Translational Medicine
The genetic key to conquering cholera
Researchers have long understood that genetics can play a role in how susceptible people are to contracting cholera, but a team of Harvard scientists is now uncovering evidence of genetic changes that might also help protect some people from contracting the deadly disease.

Contact: Peter Reuell
preuell@fas.harvard.edu
617-496-8070
Harvard University

Public Release: 17-Jul-2013
Nutrition for Growth Summit
Conflict threatens global nutrition progress, new report warns
Major progress in tackling child undernutrition in some of the world's toughest countries is under threat as military and security funding takes precedence, a new report from aid agency World Vision warns.

Contact: Holly Frew
hfrew@worldvision.org
202-596-8509
World Vision

Public Release: 16-Jul-2013
Health Affairs
Health Affairs July issue contains global innovation studies from India And Brazil
Two new studies, in Health Affairs July 2013 issue, describe health success stories outside the US.

Contact: Sue Ducat
sducat@projecthope.org
301-841-9962
Health Affairs

Public Release: 16-Jul-2013
Research leads to affordable technology to fight mosquito-borne diseases
Technology that hampers mosquitoes' host-seeking behavior, identified at the University of California, Riverside in 2011, has led to the development of the world's first product that blocks mosquitoes' ability to efficiently detect carbon dioxide, their primary method of tracking human blood meals.
Bill and Melinda Gates Foundation, National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 12-Jul-2013
PLOS Neglected Tropical Diseases
Exploring gender dimensions of treatment programs for neglected tropical diseases in Uganda
Males and females face different challenges in accessing treatment for neglected tropical diseases, according to a new study from researchers at the University of Toronto Dalla Lana School of Public Health, Uganda Ministry of Health and Imperial College London. The study, published by PLOS Neglected Tropical Diseases on July 11, explores the role of gender in access to treatment in the Uganda National Neglected Tropical Disease Control Program.

Contact: Heather Rilkoff
heather.rilkoff@mail.utoronto.ca
647-206-8328
University of Toronto

Public Release: 11-Jul-2013
Nucleic Acid Therapeutics
New therapeutic strategy targets dengue virus using artificial microRNAs
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide.

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 11-Jul-2013
3 neglected-disease treatments newly added to WHO Essential Medicines List for paediatric use
This week the World Health Organization (WHO) released its newly updated 4th WHO Model List of Essential Medicines for Children, in which three treatments developed by the Drugs for Neglected Diseases initiative and its partners have now been included. One treatment was also added to the 18th WHO Model List of Essential Medicines for adults.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Showing releases 476-500 out of 891.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>